PRFX

PainReform Ltd.

PRFX | $0.841 -5.48% -5.8% 23K

(0.0% 1d) (-50.6% 1m) (-83.8% 1y) (0.0% 2d) (4.7% 3d) (2.2% 7d) (22.1% volume)
Earnings Calendar: 2022-11-14
Market Cap: $ 1,704,070
http://www.painreform.com
Sec Filling | Patents | n/a employees

PainReform Ltd. operates as a pharmaceutical company. It develops and markets pharmaceuticals. The firm focuses on developing reformulation of pain therapeutics, PainReform applies its propriety formulation technologies to prolong and enhance efficacy, reduce adverse effects shortening recovery time and reduce the need of augmentation with drugs such as opioids and NSAIDS. The company was founded by Lihu Avitov and Dan Teleman in 2007 and is headquartered in Herzliya, Israel.

education opioid israel msa

add to watch list Paper trade email alert is off

Press-releases

PainReform Announces Closing of $4 Million Public Offering
Published: 2024-04-18 (Crawled : 18:00) - globenewswire.com
PRFX | $0.841 -5.48% -5.8% 23K

Health Technology

| 2.18% | O: -0.11% H: 2.3% C: 1.15%
million offering

PainReform Announces Pricing of $4 Million Public Offering
Published: 2024-04-16 (Crawled : 12:00) - globenewswire.com
PRFX | $0.841 -5.48% -5.8% 23K

Health Technology

| -17.21% | O: -23.72% H: 3.66% C: -1.22%
million offering

PainReform’s Non-Opiate Topical Treatment for Post-Surgical Pain Relief Outperforms Leading Competitor Under Various Testing Conditions
Published: 2024-04-09 (Crawled : 13:00) - globenewswire.com
PRFX | $0.841 -5.48% -5.8% 23K

Health Technology

| -47.65% | O: 15.88% H: 29.44% C: -23.35%
treatment for

PainReform Reaches 50% Enrollment in the Second Part of its Phase 3 Clinical Trial of PRF-110 in Bunionectomy
Published: 2024-04-02 (Crawled : 12:30) - globenewswire.com
PRFX | $0.841 -5.48% -5.8% 23K

Health Technology

| -48.85% | O: 9.2% H: 0.0% C: -8.95%
prf-110 trial

PainReform Provides Year-End Business Update
Published: 2024-03-01 (Crawled : 13:00) - globenewswire.com
PRFX | $0.841 -5.48% -5.8% 23K

Health Technology

| -53.16% | O: 4.74% H: 22.11% C: 15.92%
business update

PainReform to Present at the Microcap Conference in Atlantic City
Published: 2024-01-22 (Crawled : 13:30) - globenewswire.com
PRFX | $0.841 -5.48% -5.8% 23K

Health Technology

| -60.37% | O: 0.39% H: 0.26% C: -7.73%
conference atlantic city microcap

PainReform Reports Successful Head-to-Head Comparison of PRF-110 Versus Market Leading Post Surgical Analgesia for Extended Postoperative Pain Relief
Published: 2024-01-03 (Crawled : 13:30) - globenewswire.com
PRFX | $0.841 -5.48% -5.8% 23K

Health Technology

| -65.5% | O: 7.36% H: 0.36% C: -6.84%
prf-110 market

PainReform Announces Exercise of Warrants for Approximately $1.3 Million in Gross Proceeds
Published: 2023-12-26 (Crawled : 23:00) - globenewswire.com
PRFX | $0.841 -5.48% -5.8% 23K

Health Technology

| -69.47% | O: 1.54% H: 8.11% C: 2.53%
million

PainReform Provides Business Update for the Third Quarter of 2023
Published: 2023-11-15 (Crawled : 21:00) - globenewswire.com
PRFX | $0.841 -5.48% -5.8% 23K

Health Technology